Pulmonary Hypertension in Hypertensive Patients: Association with Diastolic Dysfunction and Increased Pulmonary Vascular Resistance

被引:4
作者
Mukherjee, Monica [1 ]
Mehta, Nishaki K. [2 ]
Connolly, James J. [3 ]
Dusaj, Raman S. [4 ]
Choi, Brian G. [2 ]
Katz, Richard J. [2 ]
Lewis, Jannet F. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21224 USA
[2] George Washington Univ, Med Ctr, Div Cardiol, Washington, DC 20037 USA
[3] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
[4] Univ Florida, Sch Med, Div Cardiol, Gainesville, FL USA
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2014年 / 31卷 / 04期
关键词
pulmonary hypertension; echocardiography; diastolic dysfunction; hypertension; elderly; PRESERVED EJECTION FRACTION; CONGESTIVE-HEART-FAILURE; NONINVASIVE ESTIMATION; SILDENAFIL; INHIBITION; EXERCISE; SOCIETY;
D O I
10.1111/echo.12393
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary hypertension (PH) in patients with systemic hypertension and preserved ejection fraction (PEF) has been described. However, the pathophysiology and consequences are not entirely clear. We sought to distinguish the clinical and anatomic features among hypertensive patients with or without coexistent PH. MethodsEchocardiograms and records of hypertensive patients with left ventricular (LV) hypertrophy and PEF from January 2009 to January 2011 were reviewed. We identified 174 patients, including 36 with PH (calculated pulmonary artery systolic pressure [PASP]35mmHg), and 138 with normal pulmonary pressures. ResultsHypertensive patients with PH were older (7613 vs. 65 +/- 13years, P<0.0001), more often female (91, 70%), had lower estimated glomerular filtration rate (eGFR) (63 +/- 44 vs. 88 +/- 48mL/min, P=0.002), and higher pro-BNP levels (3141 +/- 4253 vs. 1219 +/- 1900pg/mL, P=0.003). PH patients also had larger left atrial areas (23.7 +/- 3.8 vs. 20.8 +/- 4.6cm(2), P=0.002), evidence of diastolic dysfunction (i.e., septal E/e 17.6 +/- 8.6 vs. 12.7 +/- 4.4, P=0.0005), and higher calculated peripheral vascular resistance (PVR) (2.3 +/- 1.1 vs. 1.6 +/- 0.4, P<0.0001). Both PVR and septal E/e showed strong linear correlation with PASP (P<0.0001 and P<0.0001, respectively). ConclusionsHypertension in elderly patients is frequently complicated by LV diastolic dysfunction and secondary PH. These hypertensive patients tended to have reduced renal function and higher pro-BNP. Because of the known morbidity and mortality associated with PH, these observations have potentially important implications for target medical therapy.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 35 条
[1]   A simple method for noninvasive estimation of pulmonary vascular resistance [J].
Abbas, AE ;
Fortuin, FD ;
Schiller, NB ;
Appleton, CP ;
Moreno, CA ;
Lester, SJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :1021-1027
[2]   Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans [J].
Borlaug, BA ;
Melenovsky, V ;
Marhin, T ;
Fitzgerald, P ;
Kass, DA .
CIRCULATION, 2005, 112 (17) :2642-2649
[3]   A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) [J].
Califf, RM ;
Adams, KF ;
McKenna, WJ ;
Gheorghiade, M ;
Uretsky, BF ;
McNulty, SE ;
Darius, H ;
Schulman, K ;
Zannad, F ;
HandbergThurmond, E ;
Harrell, FE ;
Wheeler, W ;
SolerSoler, J ;
Swedberg, K .
AMERICAN HEART JOURNAL, 1997, 134 (01) :44-54
[4]   Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure [J].
Delgado, JF ;
Conde, E ;
Sánchez, V ;
López-Rios, F ;
Gómez-Sánchez, MA ;
Escribano, P ;
Sotelo, T ;
de la Cámara, AG ;
Cortina, J ;
de la Calzada, CS .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (06) :1011-1016
[5]   Determinants of pulmonary hypertension in left ventricular dysfunction [J].
EnriquezSarano, M ;
Rossi, A ;
Seward, JB ;
Bailey, KR ;
Tajik, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (01) :153-159
[6]   The other pulmonary hypertension: heart failure with preserved ejection fraction [J].
Frost, A. E. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 :3-5
[7]   Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure [J].
Ghio, S ;
Gavazzi, A ;
Campana, C ;
Inserra, C ;
Klersy, C ;
Sebastiani, R ;
Arbustini, E ;
Recusani, F ;
Tavazzi, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :183-188
[8]   Long-term use of sildenafil in the therapeutic management of heart failure [J].
Guazzi, Marco ;
Samaja, Michele ;
Arena, Ross ;
Vicenzi, Marco ;
Guazzi, Maurizio D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (22) :2136-2144
[9]   Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure [J].
Katz, SD ;
Balidemaj, K ;
Homma, S ;
Wu, H ;
Wang, J ;
Maybaum, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :845-851
[10]   Prognostic importance of pulmonary hypertension in patients with heart failure [J].
Kjaergaard, Jesper ;
Akkan, Dilek ;
Iversen, Kasper Karmark ;
Kjoller, Erik ;
Kober, Lars ;
Torp-Pedersen, Christian ;
Hassager, Christian .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08) :1146-1150